Cite
[Long-acting beta-2 agonists in pediatric asthma therapy--friend or foe].
MLA
Kurz, Herbert, et al. “[Long-Acting Beta-2 Agonists in Pediatric Asthma Therapy--Friend or Foe].” Wiener Klinische Wochenschrift, vol. 118, no. 11–12, June 2006, pp. 362–64. EBSCOhost, https://doi.org/10.1007/s00508-006-0607-0.
APA
Kurz, H., Eber, E., Frischer, T., Götz, M., Horak, E., Riedler, J., Schmitzberger, R., & Zach, M. (2006). [Long-acting beta-2 agonists in pediatric asthma therapy--friend or foe]. Wiener Klinische Wochenschrift, 118(11–12), 362–364. https://doi.org/10.1007/s00508-006-0607-0
Chicago
Kurz, Herbert, Ernst Eber, Thomas Frischer, Manfred Götz, Elisabeth Horak, Josef Riedler, Rudolf Schmitzberger, and Maximilian Zach. 2006. “[Long-Acting Beta-2 Agonists in Pediatric Asthma Therapy--Friend or Foe].” Wiener Klinische Wochenschrift 118 (11–12): 362–64. doi:10.1007/s00508-006-0607-0.